Skip to main content
. 2021 Apr 30;11:664927. doi: 10.3389/fonc.2021.664927

Figure 2.

Figure 2

Loss of RIPK3 aggravates tumor burden in ApcMin/+ mice. (A) Polyps in representative intestines from Apcmin/+ and Apcmin/+Ripk3-/- mice. (B, C) Number of polyps formed (B) and tumor load (C) in 16-week-old Apcmin/+ and Apcmin/+Ripk3-/- intestines. (D) Distribution of tumor size in 16-week-old Apcmin/+ and Apcmin/+Ripk3-/- mice. (E) Images of the H&E-stained intestines from Apcmin/+ and Apcmin/+Ripk3-/- mice. (F, G) Hematocrit (F) and thymus weight (G) of 16-week-old WT, Ripk3-/-, Apcmin/+ and Apcmin/+Ripk3-/- mice. (H) Survival of Apcmin/+ and Apcmin/+Ripk3-/- mice as indicated. *p < 0.05, **p < 0.01 and ***p < 0.001 versus Apcmin/+ mice. (I, J) Whole intestines and colonic crypts were isolated from 16-week-old Apcmin/+ and Apcmin/+Ripk3-/- mice. PCNA and cleavage of caspase-3 were analyzed by western blotting. *p < 0.05 and ***p < 0.001 versus Apcmin/+ mice.